PA
RVNC
Perceptive Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-600,000
| Closed | -$1.54M | – | 120 |
|
|
2024
Q2 | $1.54M | Hold |
600,000
| – | – | 0.04% | 94 |
|
|
2024
Q1 | $2.95M | Buy |
+600,000
| New | +$2.95M | 0.05% | 95 |
|
|
2023
Q1 | – | Sell |
-729,097
| Closed | -$13.5M | – | 108 |
|
|
2022
Q4 | $13.5M | Sell |
729,097
-79,574
| -10% | -$1.47M | 0.38% | 52 |
|
|
2022
Q3 | $21.8M | Buy |
808,671
+236,157
| +41% | +$6.38M | 0.63% | 42 |
|
|
2022
Q2 | $7.91M | Buy |
572,514
+435,000
| +316% | +$6.01M | 0.25% | 69 |
|
|
2022
Q1 | $2.68M | Buy |
+137,514
| New | +$2.68M | 0.05% | 114 |
|
|
2020
Q3 | – | Sell |
-65,839
| Closed | -$1.61M | – | 144 |
|
|
2020
Q2 | $1.61M | Sell |
65,839
-859,161
| -93% | -$21M | 0.03% | 104 |
|
|
2020
Q1 | $13.7M | Buy |
925,000
+104,623
| +13% | +$1.55M | 0.36% | 52 |
|
|
2019
Q4 | $13.3M | Buy |
+820,377
| New | +$13.3M | 0.26% | 56 |
|
|
2018
Q2 | – | Sell |
-618,957
| Closed | -$19.1M | – | 146 |
|
|
2018
Q1 | $19.1M | Buy |
618,957
+218,957
| +55% | +$6.74M | 0.53% | 47 |
|
|
2017
Q4 | $14.3M | Buy |
+400,000
| New | +$14.3M | 0.47% | 49 |
|